{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:04:13Z","timestamp":1784347453288,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.virusres.2026.199768","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:20:52Z","timestamp":1781911252000},"page":"199768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanisms and therapeutic implications of galectins regulating Epstein\u2013Barr virus infection"],"prefix":"10.1016","volume":"370","author":[{"given":"Jie-Yu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albright Dew","family":"Baua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zih-Syuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-I","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchai","family":"Assavalapsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunee","family":"Thitithanyanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4183-3872","authenticated-orcid":false,"given":"Sheng-Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.virusres.2026.199768_bib0052","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"19","key":"10.1016\/j.virusres.2026.199768_bib0046","doi-asserted-by":"crossref","first-page":"E4396","DOI":"10.1073\/pnas.1718921115","article-title":"Molecular mechanism to recruit galectin-3 into multivesicular bodies for polarized exosomal secretion","volume":"115","author":"Banfer","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.virusres.2026.199768_bib0008","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.3390\/cancers13205189","article-title":"Epstein-Barr virus-associated malignancies and immune escape: the role of the tumor microenvironment and tumor cell evasion strategies","volume":"13","author":"Bauer","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.virusres.2026.199768_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1059133","article-title":"EBV-associated diseases: current therapeutics and emerging technologies","volume":"13","author":"Chakravorty","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.virusres.2026.199768_bib0030","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/fvl-2018-0120","article-title":"The Epstein-Barr virus LMP1 interactome: biological implications and therapeutic targets","volume":"13","author":"Cheerathodi","year":"2018","journal-title":"Future Virol."},{"issue":"1","key":"10.1016\/j.virusres.2026.199768_bib0045","article-title":"The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9\/Tim-3-related changes in the tumour microenvironment","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2026.199768_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2021.108367","article-title":"Lectins: biological significance to biotechnological application","volume":"506","author":"Chettri","year":"2021","journal-title":"Carbohydr. Res."},{"issue":"20","key":"10.1016\/j.virusres.2026.199768_bib0001","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.virusres.2026.199768_bib0027","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1182\/blood-2007-01-066100","article-title":"Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma","volume":"110","author":"Gandhi","year":"2007","journal-title":"Blood"},{"issue":"2\u20133","key":"10.1016\/j.virusres.2026.199768_bib0004","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12026-014-8496-1","article-title":"The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease","volume":"58","author":"Hatton","year":"2014","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.virusres.2026.199768_bib0003","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12985-023-02187-9","article-title":"Epstein-Barr virus infection: the micro and macro worlds","volume":"20","author":"Huang","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2026.199768_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.949264","article-title":"Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation","volume":"13","author":"Humphries","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.virusres.2026.199768_bib0020","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2217\/fvl.15.80","article-title":"EBV glycoproteins: where are we now?","volume":"10","author":"Hutt-Fletcher","year":"2015","journal-title":"Future Virol."},{"key":"10.1016\/j.virusres.2026.199768_bib0002","doi-asserted-by":"crossref","first-page":"ftae002","DOI":"10.1093\/femspd\/ftae002","article-title":"Awakening the sleeping giant: Epstein-Barr virus reactivation by biological agents","volume":"82","author":"Indari","year":"2024","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.virusres.2026.199768_bib0037","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2021.04.011","article-title":"The TIM3\/Gal9 signaling pathway: an emerging target for cancer immunotherapy","volume":"510","author":"Kandel","year":"2021","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.virusres.2026.199768_bib0021","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational design of an Epstein-Barr Virus vaccine targeting the receptor-binding site","volume":"162","author":"Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2026.199768_bib0044","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1471-2407-6-283","article-title":"Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9","volume":"6","author":"Keryer-Bibens","year":"2006","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.virusres.2026.199768_bib0029","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1182\/blood-2008-02-142596","article-title":"Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells","volume":"113","author":"Klibi","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.virusres.2026.199768_bib0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00018-019-03288-x","article-title":"Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses","volume":"77","author":"Laubli","year":"2020","journal-title":"Cell Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.virusres.2026.199768_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003253","article-title":"TIM-3 does not act as a receptor for galectin-9","volume":"9","author":"Leitner","year":"2013","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.virusres.2026.199768_bib0034","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3892\/mmr.2021.12009","article-title":"Galectin\u20113 facilitates the proliferation and migration of nasopharyngeal carcinoma cells via activation of the ERK1\/2 and Akt signaling pathways, and is positively correlated with the inflammatory state of nasopharyngeal carcinoma","volume":"23","author":"Li","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.virusres.2026.199768_bib0032","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1248\/bpb.b24-00872","article-title":"The tumor microenvironment remodeled by Epstein-Barr Virus: from primary site to distant metastatic niche","volume":"48","author":"Li","year":"2025","journal-title":"Biol. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.virusres.2026.199768_bib0048","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","article-title":"The role of galectins in immunity and infection","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virusres.2026.199768_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.640207","article-title":"The role of EBV-encoded LMP1 in the NPC tumor microenvironment: from function to therapy","volume":"11","author":"Lo","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.virusres.2026.199768_bib0042","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001849","article-title":"Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors","volume":"8","author":"Okoye","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"16","key":"10.1016\/j.virusres.2026.199768_bib0033","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2010-11-320481","article-title":"Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders","volume":"117","author":"Ouyang","year":"2011","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.virusres.2026.199768_bib0028","doi-asserted-by":"crossref","first-page":"13326","DOI":"10.1128\/JVI.79.21.13326-13337.2005","article-title":"In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin","volume":"79","author":"Pioche-Durieu","year":"2005","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2026.199768_bib0011","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.immuni.2012.03.004","article-title":"Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer","volume":"36","author":"Rabinovich","year":"2012","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.virusres.2026.199768_bib0035","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1158\/1078-0432.CCR-07-4709","article-title":"AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features","volume":"14","author":"Rodig","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.virusres.2026.199768_bib0036","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1535-6108(04)00024-8","article-title":"Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege","volume":"5","author":"Rubinstein","year":"2004","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.virusres.2026.199768_bib0051","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1385690","article-title":"Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy","volume":"7","author":"Sabatos-Peyton","year":"2018","journal-title":"Oncoimmunology"},{"issue":"8","key":"10.1016\/j.virusres.2026.199768_bib0043","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.it.2011.05.003","article-title":"Emerging Tim-3 functions in antimicrobial and tumor immunity","volume":"32","author":"Sakuishi","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.virusres.2026.199768_bib0019","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13557","article-title":"Structural basis for Epstein-Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins","volume":"7","author":"Sathiyamoorthy","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.virusres.2026.199768_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000882","article-title":"Galectin-9\/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response","volume":"6","author":"Sehrawat","year":"2010","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.virusres.2026.199768_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0042-6822(89)90345-0","article-title":"Characterization of N- and O-linked oligosaccharides of glycoprotein 350 from Epstein-Barr virus","volume":"170","author":"Serafini-Cessi","year":"1989","journal-title":"Virology"},{"issue":"15","key":"10.1016\/j.virusres.2026.199768_bib0024","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.00108-09","article-title":"Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification","volume":"83","author":"Shannon-Lowe","year":"2009","journal-title":"J. Virol."},{"issue":"4927","key":"10.1016\/j.virusres.2026.199768_bib0013","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.2552581","article-title":"Lectins as cell recognition molecules","volume":"246","author":"Sharon","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.virusres.2026.199768_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1297994","article-title":"Epstein-Barr virus: the mastermind of immune chaos","volume":"15","author":"Silva","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2026.199768_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105881","article-title":"The therapeutic potential of galectin-3 inhibition in fibrotic disease","volume":"130","author":"Slack","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"12","key":"10.1016\/j.virusres.2026.199768_bib0038","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/JVI.00239-09","article-title":"Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ T cells correlates with increased resistance to galectin-1-mediated suppression","volume":"83","author":"Smith","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199768_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2022.101260","article-title":"Therapeutic approaches to Epstein-Barr virus cancers","volume":"56","author":"Soldan","year":"2022","journal-title":"Curr. Opin. Virol."},{"issue":"11","key":"10.1016\/j.virusres.2026.199768_bib0023","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nsmb1161","article-title":"Structure of the Epstein-Barr virus major envelope glycoprotein","volume":"13","author":"Szakonyi","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"12","key":"10.1016\/j.virusres.2026.199768_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105400","article-title":"The universe of galectin-binding partners and their functions in health and disease","volume":"299","author":"Troncoso","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.virusres.2026.199768_bib0014","doi-asserted-by":"crossref","first-page":"cwaf026","DOI":"10.1093\/glycob\/cwaf026","article-title":"The multifaceted roles of galectins in host-virus interactions: a comprehensive overview","volume":"35","author":"Tung","year":"2025","journal-title":"Glycobiology"},{"key":"10.1016\/j.virusres.2026.199768_bib0017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4614-0106-3_2","article-title":"Galectins as pattern recognition receptors: structure, function, and evolution","volume":"946","author":"Vasta","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.virusres.2026.199768_bib0015","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jmii.2019.09.005","article-title":"The role of galectins in virus infection - A systemic literature review","volume":"53","author":"Wang","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.virusres.2026.199768_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2024.101911","article-title":"Galectins and host-pathogen interactions: the roles in viral infections","volume":"76","author":"Wang","year":"2024","journal-title":"Semin. Immunol."},{"issue":"10","key":"10.1016\/j.virusres.2026.199768_bib0009","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"1863","author":"Watanabe","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"1","key":"10.1016\/j.virusres.2026.199768_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04932-22","article-title":"Galectin-9 facilitates Epstein-Barr Virus latent infection and lymphomagenesis in Human B cells","volume":"11","author":"Xu","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"7","key":"10.1016\/j.virusres.2026.199768_bib0039","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/vim.2022.0203","article-title":"Expression and clinical significance of peripheral blood IL-17A, IL-22, tim-3, and gal-9 in children with infectious mononucleosis","volume":"36","author":"Xu","year":"2023","journal-title":"Viral Immunol."},{"issue":"3","key":"10.1016\/j.virusres.2026.199768_bib0025","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3390\/v15030714","article-title":"Epstein-Barr Virus history and pathogenesis","volume":"15","author":"Yu","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.virusres.2026.199768_bib0047","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1038\/s41467-025-59605-5","article-title":"Autophagy-independent role of ATG9A vesicles as carriers for galectin-9 secretion","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:53:28Z","timestamp":1784346808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170226000870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"alternative-id":["S0168170226000870"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199768","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and therapeutic implications of galectins regulating Epstein\u2013Barr virus infection","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199768"}}